RTW Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,125,000
Closed -$82.3M 77
2025
Q1
$82.3M Buy
1,125,000
+153,000
+16% +$12.6M 1.26% 26
2024
Q4
$80.4M Buy
+972,000
New +$76.7M 1.22% 28
2023
Q1
Sell
-747,685
Closed -$55.5M 65
2022
Q4
$55.5M Hold
747,685
1.13% 22
2022
Q3
$44.5M Sell
747,685
-373,842
-33% -$22.5M 1.03% 31
2022
Q2
$63M Sell
1,121,527
-560,764
-33% -$36.9M 1.63% 21
2022
Q1
$124M Buy
1,682,291
+11,480
+0.7% +$798K 2.57% 11
2021
Q4
$121M Hold
1,670,811
1.76% 16
2021
Q3
$128M Hold
1,670,811
1.93% 15
2021
Q2
$130M Hold
1,670,811
1.95% 16
2021
Q1
$103M Buy
1,670,811
+29,952
+2% +$1.9M 1.61% 19
2020
Q4
$107M Buy
+1,640,859
New +$94.3M 1.8% 15

Other funds holding GMED

RTW Investments's GMED Position: Q2 2025 in Review

RTW Investments sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 1,125,000 shares — an estimated $82.3M sold.

RTW Investments first reported a position in GMED in Q4 2020 and held it in 11 quarters. The position peaked at $130M in Q2 2021. 481 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • RTW Investments reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • RTW Investments sold 1,125,000 Globus Medical shares in Q2 2025, an estimated $82.3M.
  • RTW Investments first reported a position in Globus Medical in Q4 2020 and held it in 11 quarters.
  • RTW Investments's Globus Medical position peaked at $130M in Q2 2021.
  • 481 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on RTW Investments's 13F filing for Q2 2025, filed 14 Aug 2025.